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BACTEREMIA IN THE HIV-INFECTED PATIENT 
The importance of bacterial infection in the HIV- 
infected patient has been underestimated for years [1,2]. 
Bacterial complications, however, are among the most 
important causes of hospital admission, are frequently 
recurrent and occasionally coniplicated by bacteremia. 
At least 50% of HIV-infected patients suffer one or 
more bacterial infections during the course of their 
disease. 
Incidence 
The precise incidence of bacteremia in the HIV- 
infected patient has not been adequately established but 
figures reported range from 0 to 27%. 
Meyer et a1 [3], studying a cohort of 837 HIV- 
infected adults over a five-year period, identified 63 
patients with 76 bacteremic/fungemic episodes. Coni- 
pared with an age-matched reference population with 
an incidence of 10.3 bacteremias per 10,000 person- 
years, the incidence was 170 among pre-AIDS patients 
and 3,200 among AIDS patients. 
Fichtenbaum et a1 [4], reviewed all episodes of 
non-niycobacterial bactereinias in HIV-infected patients 
from 1990 to 1991 in their institution. Forty-five 
patients had a total of 63 episodes of bacteremia (9% of 
689 HIV-related hospitalizations). 
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At our institution, among the 12,144 episodes of 
significant bacteremia registered between 1985 and 
1996, 1,335 occurred in known HIV-infected indi- 
viduals. At any given time, 2,596 of patients hospitalized 
in our institution are HIV-infected. However, HIV- 
infected patients represent 11% of all episodes of 
bactereniia and 10% of all bactereniic patients. 
Pathogenesis and risk factors 
Predisposing factors for the infection are: low CD4 
count, permanent intravenous lines, neutropenia and 
active intravenous drug abuse (IVDA) [4]. Keiser et a1 
[5], in a case control study, showed that neutropenia is 
clearly related to the development of bacterial infection 
in HIV-infected patients. The experimental group 
was made up of 29 patients infected with HIV who 
also had an absolute neutrophil count of less than 
1,000 celldmm’, and were paired with 29 control 
subjects infected with HIV who had been matched for 
age, sex, CD4 count, and month and year of entry. The 
frequency of bacteremia was 12.6 per 100 patient 
months among the experimental group compared with 
a frequency of 0.87 per 100 patient months among the 
control group. Multivariate analysis demonstrated that 
neutropenia and the presence of a central venous 
catheter were significant risks for bacteremia. 
Etiology 
Regarding etiology, the most common episodes of 
bloodstream infections in the HIV-infected patient are 
community-acquired and frequently caused by niicro- 
organisms such as Stuphyloroccus uuveus, Streptococcus 
pneumoniur, Sulmonella spp. and ff. infltrenzae [6,7]. 
The etiology of bacteremic infections iri HIV- 
positive and HIV-negative patients in our institution 
is compared in Table 1. HIV-positive patients have 
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Table 1 Comparison of etiologic agents of bacteremia 
between HIV-positive and HIV-negative patients at our 
hospital 
Microorganisms 
% HIV % HIV 
(+) episodes (-) episodes 
S. aureus 33.3 17.6 
CNS 17.3 19.3 
S. pneumoniae 12.5 5.8 
Salmonella spp. 7.6 2.3 
E. coli 5.4 19.6 
Enterococcus spp. 5 8.2 
S. viridans 4 3.2 
S. pyogenes 3 0.7 
Caudida spp. 3 1.9 
l? aeruginosa 3 3.5 
Haemophilus spp. 2 1.2 
Cryptococcus neojormans 1.4 0 
Gram-negative NFR 0.8 0.5 
Anaerobic bacteria 1.2 3.5 
S. maltophilia 0.7 0.5 
Corynebacterinm spp. 0.7 0.6 
Proteus spp. 0.5 2.8 
Pseudomonas spp. 0.5 0.4 
Acinetobacter spp. 0.5 I .3 
Klebsiella spp. 0.5 4.4 
S. agalactiae 0.4 0.9 
Campylobacter spp. 0.4 0.2 
Bacillus spp. 0.3 0.1 
group C 0.2 0.1 
Citrobacter spp. 0.2 0.5 
Micrococcus spp. 0.1 0.3 
Polymicrobial episodes 20 9 
Serratia spp. 0.3 1.3 
Steptococcus p hemolytic 
Listeria monocytogenes 0.1 0.3 
significantly more bacteremias caused by S. aureus, 
S. pneumoniae, Salmonella spp., S. pyogenes, Cryptococcus 
neofrmans, Candida spp, and Haemophilus spp. and fewer 
episodes due to E. coli, and other Enterobacteviaceae, 
Enterococcus spp. and anaerobic microorganisms. Episodes 
of polymicrobial bacteremia were significantly more 
frequent in HIV-positive patients than in the HIV- 
negative group. 
HIV-infected patients have a higher proportion of 
Gram-positives and yeasts than the HIV-negative 
patients (72.5% and 4.2% vs. 55% and 1.896, respec- 
tively, p<O.O01) and a lesser proportion of Gram- 
negatives and anaerobes (22.2% and 1.1% vs. 39.8% and 
3.4%, respectively). 
The very high number of S. aweus bacteremias in 
our patients is probably due to the fact that an 
important proportion of our HIV-positive population 
is formed by intravenous drug abusers (IVDA). How- 
ever, in the experience of Meyer et a1 [3], mainly with 
a homosexual population, staphylococcal infections also 
comprised 35% of all episodes, while the HIV-related 
pathogens Streptococcus pneumoniae, Salmonella spp. and 
C. neoformans together accounted for 34%. 
The second microorganism responsible for bac- 
teremia is Coagulase Negative Staphylococcus (CNS). 
This represents catheter-related bacteremias in most 
cases. It is well known that the incidence of infection 
of central catheters is higher in HIV-positive than in 
HIV-negative patients. 
S. pneumoniae is the third cause. It is well known 
that the incidence of pneumococcal pneumonia in 
HIV-positive patients is between 10 and 100 times 
higher than in the remaining population, and a 
higher proportion of them are bacteremic [8].  At our 
institution, the recent increase of pneumococcal 
bacteremia during the last decade is mostly due to this 
increase of infection in the HIV population [9]. 
Bacteremic pneumococcal pneumonia in the middle- 
aged adult is a warning of immunodeficiency and an 
HIV test should be offered to patients under such 
conditions [lo, 111. Clinical behavior of pneumococcd 
pneumonia and bacteremia is similar in both HIV- 
positive and -negative groups, but in our population, 
and that of others, mortality is not greater in the HIV- 
infected patient [12,13]. 
Another relevant microorganism group in the 
HIV-infected individual is Group A Streptococcus 
(GAS). We recently reported on a prospective evaluation 
of 100 patients with GAS bacteremia evaluated in our 
hospital over a ten-year period [14]. Sixty-two patients 
were IVDA and 52 were infected with HIV, five of 
these were in the non-IVDA group. During the last five 
years of the study, GAS bacteremia in our hospital was 
39 times more frequent in HIV-infected patients than 
in patients without HIV. However, the incidence of 
streptococcal toxic shock syndrome (STSS) was lower 
in the IVDA group. This entity should be suspected in 
HIV-infected IVDA with skin lesions and fever. 
We have also demonstrated a higher incidence of 
group C streptococcal bacteremias in the HIV-infected 
population [ 151. 
In contrast, Listeria monocytogenes is remarkably 
uncommon in the HIV-positive population. Through- 
out the twelve years of our study, we had 36 episodes 
of L. monocytogenes of which only two occurred in 
HIV-infected individuals. There has been considerable 
discussion regarding the reasons for this but the 
frequent use of cotrimoxazole prophylaxis is not 
sufficient to explain it. The experience of Jurado et a1 
[16] is not quite the same. They studied the incidence, 
demographics and clinical outcome of infections due 
to L. monocytogenes in HIV-infected individuals in a 
prospective population-based survey. During a two- 
year study period, 37 cases of invasive listeriosis occurred 
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in metropolitan Atlanta (annual incidence, 0.8 cases per 
100,000 population). Seven of these cases occurred in 
known HIV-infected individuals (19% of all cases). The 
estimated incidence of listeriosis among HIV-infected 
patients in metropolitan Atlanta was 52 cases per 
100,000 patients per year, and among patients with 
AIDS 115 cases per 100,000 patients per year, rates 
65-145 times higher than those among the general 
population. HIV-associated cases occurred in adults 
who were 29-62 years of age and in postnatal infants 
who were two and six months of age. Mortality among 
the HIV-infected group was 29%. 
With regard to Gram-negatives, it is worth discussing 
microorganisms such as Salmonella spp., Haemophilus 
spp., P aeruginosa and Campylobacter spp. 
Salmonella typki is particularly uncommon in HIV- 
infected patients and an association between HIV and 
S. typki has only been anecdotally documented [17]. 
O n  the contrary, non-typhoid species have traditionally 
been the cause of bloodstream infections in many HIV- 
infected patients [1,17-231. Those infections were 
frequently relapsing and sometimes required long-term 
therapy. 
Between 1982 and 1989, Salmon-Ceron et a1 
[19] reported 68 patients with non-typhi Salmonella 
bactereniia among HIV-infected patients hospitalized 
in four infectious and tropical diseases departments in 
Paris. Clinical symptoms included fever (100%) and 
gastrointestinal symptoms (53%). The mean CD4 cell 
count was 118+145 per mm'. The serotypes were 
mainly S. Typhimurium, S. Enteritidis and S.  Dublin. 
Under antibiotic therapy, the course of the disease was 
initially favorable in 98.5% of the cases. No relapse was 
observed in patients taking zidovudine or antibio- 
prophylaxis, but 53% of the patients without prophylaxis 
relapsed. The overall survival of the cohort was 25% 
after 18 months. Focal suppurative complications in 
patients with Salmonella bacteremia, occur (only) in less 
than 5% of adults without HIV infection but in more 
than 25% of those who are HIV-infected. Infections of 
the urinary tract, lungs and soft tissue, followed by 
arthritis, endocard~tis and meningitis are most frequently 
seen 121,221. In recent years there has been a dramatic 
decrease in Salrnorzella bacteremia in the HIV-infected 
population, not only due to the better anti-retroviral 
therapy but also to the widespread use of cotrimoxazole 
prophylaxis in severely innnunocompromised patients 
and the direct anti-Salmonella activity of zidovudine. 
Haemophilus injueuzae is another microorganism 
which is clearly associated with respiratory tract infec- 
tions in the HIV-infected patient [241. These infections 
are only occasionally bacteremic. Very recently we 
reported our experience with bloodstream infections 
caused by Haemoplzilus spp in our institution, which 
constitutes the largest series reported from a single 
center [25]. We had 116 patients with Haemophilus 
bactereniia from 1986 to 1994 (0.26 cases per 1,000 
admissions). HIV infection was the most common 
underlying condition (29%), followed by malignant 
neoplasms (1 9%) and chronic obstructive pulmonary 
disease (1 9%). Prevalence in HIV-positive patients was 
5 cases per 1,000 admissions vs. 0.2 cases per 2,000 
admissions in HIV-negative patients. The HIV-positive 
patients were significantly younger and presented more 
frequently with pneumonia. Overall mortality was 
22%. Due to the fact that most patients have non-group 
B H .  ittfluenzae infections the prospects with Hib 
vaccine are scarce. 
Bacteremic infection with Pseudomonas aeruginosa is 
an uncommon and late phenomenon in the natural 
history of the HIV infection. It occurs almost always in 
patients with less than 100 CD4 lyniphocytes per mni'. 
It may be community or nosocomially acquired and the 
most frequent source is pneumonia, followed by 
catheter-related infections and also primary bacteremias. 
The infection is frequently recurrent and associated 
with a very high mortality [26,27]. 
Campylobacter sp. is an uncommon agent of blood- 
stream infections in general but HIV infection is, in our 
experience, the most frequent underlying disease in 
cases with this problem. We had 32 episodes in 12 years 
and six of our patients had HIV infection [28]. 
Helirobacter cinaedi (formerly Campylobactev ririaedi) 
was first detected in the fecal flora of homosexual men. 
Since 1984, only about 20 cases of H .  cinaedi bacteremia 
have been published; most cases have presented as a 
non-specific febrile illness in homosexual men infected 
with HIV. Cellulitis is a common manifestation and 
bacteremia is frequently present. Microbiological diag- 
nosis can be delayed or missed by the slow growth of 
the bacterium in non-radiometric blood culture bottles 
Regarding fungernia, the high incidence of crypto- 
coccal meningitis in the HIV-infected population is 
well known. We had 19 episodes of C. ne&watis  
fungemia of which 18 were HIV infected. 
I n  the case of Candida spp. the incidence of 
niucosal infections due to Candida is extraordinarily 
high in the HIV-infected population but, surprisingly, 
fungemia is uncommon. In our institution 39 out of 
270 episodes of candidemia occurred in HIV-infected 
patients (14.4%). They were, generally, patients with 
advanced disease who had undergone itivasive nianeu- 
vers and who were receiving broad spectrum anti- 
microbial agents. 
We will not comment on the incidence and clinical 
consequences of mycobactereniia but instead refer the 
interested reader to other sources [34,35]. 
129-331. 
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Finally, the higher proportion of polymicrobial 
bacteremias in the HIV-infected group is remarkable 
(20% vs 9%). 
Patients with HIV infection have a higher incidence 
of recurrent bacteremia than the HIV-negative popu- 
lation. HIV infection was present in 18.3% of the 
patients with recurrent episodes. Recurrence is well 
known in episodes of Salmonella bacteremia but also in 
infection caused by other microorganisms such as: 
Staphylococcus aureus, Staphylococcus epidermidis, Pseudo- 
monas aeruginosa, Streptococcus pneumoniae, Campylobacter 
spp., and others. The significance is different in the 
various microorganisms. In cases like I? aevtlginosa or C. 
ueofrmans relapses are the most common cause, whereas 
in other microorganisms like S. pneumoniae the cause is 
almost always a reinfection. 
Prognosis 
The overall in-hospital mortality rate for HIV-infected 
patients with bacteremia was 24% in the experience 
of Fichtenbaum et a1 [4]. There was no significant 
difference in the in-hospital mortality rates in 
bacteremic patients with or without HIV infection. 
The overall mortality associated with clinical bacteremia 
was 12%, but nil for Salmonella spp. and S. pneumoniae 
in the experience of Meyer et a1 [3] 
Intensified hygienic precautions for intravenous 
lines should be the primary target for intervention in 
this population, and long-term cotrinioxazole prophy- 
laxis may prevent bacteremia with Salmonella spp. and 
other microorganisms [6]. 
RECURRENT BACTEREMIA 
The incidence of certain bacterial infections is in- 
creasing, probably due to aging of the population, 
progressive invasiveness of modern medicine and 
longer survival of many severely compromised patients. 
This has created an important subgroup of the popu- 
lation susceptible to recurrent infections. 
Recurrent infections are those caused by the same 
or different microorganisms, in the same anatomical 
location, which may occur after the treatment of a prior 
episode [36]. There are essentially two types ofrecurrent 
infections: relapses (recurrent infections caused by the 
same microorganism) and reinfections (recurrent in- 
fections caused by different microorganisms). 
The most common recurrent infections include: 
meningitis, otitis media, pharyngitis, the pneumonias, 
urinary tract infections, chronic prostatitis and foot 
infections. Other less common infectious diseases 
with recurrent capacity may be due to: Herpes simplex 
virus, Kricella-Zoster virus, Cytomegalovims, Pneumocystis 
carinii, Listeria monocytogenes, LRgionella spp., Aspergillus 
spp., Candida spp., Cryptococcus spp. Mycobacterium avium 
complex, Toxoplasma gondii and Strongyloides stercoralis. 
Significant bacteremia has been increasing over the 
last decade. However, recurrent bacteremia has received 
little attention, and information regarding its incidence, 
etiology, predisposing conditions and prognosis is 
scarce. We will try to summarize the available infor- 
mation and our own experience regarding the incidence, 
etiology, predisposing factors and clinical significance 
of patients with more than one episode of significant 
bacteremia. 
Concept of recurrent bacteremia 
We considered as recurrent bacteremia the existence 
of one or more subsequent episodes of significant 
bacteremia in a patient after an asymptomatic ‘clear’ 
interval of at least ten days. This was in order to avoid 
confusing recurrent episodes with episodes due only to 
prolongation of an inadequately treated infection. 
Epidemiology 
In 1994 Capdevila et a1 [37] reported their experience 
with recurrent bacteremia during a four-year period in 
a general hospital. Overall, 9% of all patients with an 
episode of bacteremia later developed at least one other 
episode. At our own center, during a 12-year period, 
we had 12144 episodes of significant bacteremia in 
10353 patients. Overall, 1145 patients had more than 
one episode of significant bacteremia, fulfilling our 
criteria of recurrent bacteremia (1 1%) [9] .  
In the experience of our institution, 25.5% of all 
patients with recurrences had more than one recurrent 
episode (Table 2). 
The time which elapsed between the first and 
subsequent episodes in our hospital varied between 10 
and 3,890 days (mean 343.22338 SD) with a median 
of 91 days (Table 3). 
Table 2 Distribution according to number of episodes of 
patients with recurrent bacteremia in Hospital General 
Universitario ‘Gregorio Marafii6n’ in Madrid 
No. of recurrent episodes No. of patients (%) 
2 episodes 853 (74.4) 
3 episodes 187 (16.3) 
4 episodes 68 (5.9) 
6 episodes 6 (0.5) 
7 episodes 5 (0.4) 
5 episodes 23 (2) 
8 episodes 3 (0.2) 
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Table 3 Time elapsed between episodes of recurrent 
bactereniia in Hospital Gencral Universitario ‘Gregorio 
Maraiion’ in Madrid 
Intervals of recurrence No. of episodes (%) 
<30 dayc 
Between 31 and 90 days 
Between 91 and 180 days 
Between 181 and 270 days 
Between 271 and 360 days 
Between 1 and 2 years 
Between 2 and years 
Between 4 and 6 years 
Between 6 and 7 years 
Between 7 and 8 years 
Between 8 and 9 years 
402 (25.1) 
361 (22.5) 
185 (11.5) 
75 (4.6) 
235 (14.6) 
150 (9.3) 
61 (3.8) 
99 (6.1) 
17 (1) 
12 (0.7) 
3 (0.1) 
Table 4 Etiology of recurrent episodes of bacteremia in 
Hospital General Universitario ‘Gregorio Maraiibn’ in 
Madrid 
Microorganisms Episodes (%) Polymicrobial (“XI) 
CNS 
S. aureus 
E.  roli 
Enterococcus spp. 
I! aerugiriora 
S. pneumouiae 
S. viridaris 
Klebsiella spp. 
Errtcrobacfer spp. 
Salmonella spp. 
Anaerobic 
Candida spp. 
Acirietobarter spp. 
Profens spp. 
Serrafia spp. 
Corynebacteriurti spp. 
Haeniophilus spp. 
Citrobacter ~ p p .  
Non-fermenting GNB 
S. nialtophilia 
Pseudonionas spp. 
~zlicrococcus spp. 
Campyhbarfer spp. 
S. aplactiae 
Crypforoccnr ne?firmans 
Brucella spp. 
A? ruenirgiridis 
S. pyogenes 
M.  mopanii 
microorganisms 
356 (22.2) 
341 (21.3) 
207 (12.9) 
90 (5.6) 
160 (10) 
65 (4) 
57 (3.5) 
54 (3.3) 
53 (3.3) 
46 (2.8) 
40 (3.1) 
72 (4.5) 
31 (1.9) 
24 (1.5) 
13 (0.8) 
10 (0.6) 
20 (1.2) 
16 (1) 
15 (0.9) 
12 (0.7) 
11 (0.6) 
8 (0.5) 
6 (0.3) 
5 (0.3) 
9 (0.5) 
4 (0.2) 
3 (0.1) 
2 (0.1) 
2 (0.1) 
72 (20.2) 
47 (13.7) 
30 (14.4) 
72 (45) 
19 (21.1) 
8 (12.3) 
19 (33.3) 
16 (29.6) 
9 (19.5) 
2 (3.7) 
18 (45) 
9 (12.5) 
6 (30) 
2 (8.3) 
2 (15.3) 
6 (37.5) 
9 (29) 
l ( 1 0 )  
3 (20) 
3 (25) 
4 (36.3) 
2 
0 
0 
0 
0 
0 
1 
2 
Etiology 
The distribution of microorganisms responsible for the 
episodes of recurrent bacterenlia in our institution is 
summarized in Table 4. Overall, the five most common 
organisms involved in recurrent episodes were: Staphylo- 
coccus spp, Esclzericlzia coli, Enterococcus, Stveptococcus pneu- 
moniae and I! aevuginosa. 
When agents responsible for recurrent episodes are 
compared with those responsible for bacteremia in 
patients without documented recurrences, S. aureus, 
S. vividans, Corynebacterium spp. and Acinetobacter spp. 
were the most frequently associated with recurrences at 
our institution. 
Patients with later recurrences had a greater pro- 
portion of certain microorganisms: s. aureus, s. viridans, 
Corynebactevium spp., Acinetobacter spp. and a lower 
proportion of E .  coli, and Pvoteus spp. 
Types of recurrent episodes 
According to the comparison of the etiologic agents of 
first and subsequent episodes, we can distinguish two 
large groups. The group of patients with recurrences 
caused by genetically identical microorganisms usually 
have either an immunosuppression and/or a local 
defect that acts as a portal of entry. A much larger group 
of patients have recurrent episodes caused by micro- 
organisms of different genus or species, or genetically 
unrelated strains. 
In our own experience, 39% of our recurrent 
episodes were due to microorganisms belonging to the 
same genus and species (but not necessarily genetically 
identical), 67% were due to microorganisms of different 
species, and in 6% of the cases patients had episodes 
caused by microorganisms of both the same and 
different species. 
The most common organisms responsible for 
recurrent bacteremias of the same species were: S. 
auveus, S. epidevmidis, E.  coli, Salmonella spp. Enterococcus, 
S. pneumoniae and J? aeruginosa. 
Predisposing factors for recurrences 
In patients with recurrence due to identical micro- 
organisms, immunosupression [38-411 and AIDS are 
frequently the underlying diseases 130, 42-44]. Also the 
presence of indwelling infected endovascular prosthetic 
material is an important consideration [45] and only 
occasionally self-induced infection should be included 
in the differential diagnosis [46]. 
Recurrences due to specific microorganisms may 
be associated with certain peculiarities. Severe infec- 
tions caused by Pseudomonas aevuginosa, for instance, 
occur occasionally in patients with advanced AIDS. 
These infections are usually recurrent and bear a poor 
prognosis. Using molecular typing techniques, we 
demonstrated homologies between the strains isolated 
in recurrent episodes of Pseudoinonas bacteremia in 
HIV-infected patients [27]. 
In a study involving 24 episodes of E.  coli 
bacteremia occurring in 11 patients, 9 patients had 
2 S38 Clinical  Microbio logy a n d  I n f e c t i o n ,  Volume 5 Supp lemen t  2 
episodes due to the same strain. The original bacterial 
focus remains within the same patient and leads to 
emergence of the infecting strain which may then cause 
further episodes of bacteremia [47]. Recurrent E. coli 
bacteremia is also a multifactorial problem that occurs 
in patients with impaired host defenses who are 
infected with virulent strains [48]. 
In two studies related to recurrent pneumococcal 
bacteremia, most patients had severe underlying diseases, 
particularly hematologic malignancies, multiple mye- 
loma or HIV infection. Most episodes were not caused 
by the same strain and most cases were not previously 
vaccinated [49,50]. However, immunocompromised 
patients with early recurrence caused by the same 
strains of S. pneumoniae have also been reported [51] 
Recurrence of Group B streptococcal bacteremia 
in infants may be associated with the original infecting 
strain or with a second acquired strain [52]. 
With regard to recurrent Staphylococcus aureus bacter- 
emia, early episodes are usually caused by a genetically 
identical strain and late episodes are usually produced 
by different strains. Recurrence usually means the 
presence of intravascular foreign bodies [53]. 
Recurrent episodes of meningococcal disease are 
frequently related to deficits in the late complement 
components, as extensive studies have demonstrated in 
the former USSR [54]. 
Significance of recurrent episodes 
Two factors were independently predictive of recurrent 
bacteremia: the presence of a rapidly fatal disease, and 
any complication during the initial episode of bacter- 
emia [37]. 
The prognosis of recurrent episodes has not been 
adequately defined but, in children with bacteremic 
and fungemic episodes, recurrence was a factor clearly 
related to mortality. Patients with recurrent bacteremia 
had a mortality of 67% [55]. 
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